Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma-Reference-Cited by-同舟云学术

Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma

Published:2022-08 Issue: Volume:82 Page:104149
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Rossi Maïlys^ORCID,Talbot Julie,Piris Patricia^ORCID,Grand Marion Le^ORCID,Montero Marie-Pierre^ORCID,Matteudi Mélanie,Agavnian-Couquiaud Emilie,Appay Romain,Keime Céline,Williamson Daniel,Buric Duje,Bourgarel Véronique,Padovani Laetitia,Clifford Steven C.,Ayrault Olivier,Pasquier Eddy,André Nicolas,Carré Manon^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference67 articles.

1. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study;Schwalbe;Lancet Oncol,2017

2. The whole-genome landscape of medulloblastoma subtypes;Northcott;Nature,2017

3. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes;Sharma;Acta Neuropathol (Berl),2019

4. Childhood medulloblastoma;Massimino;Crit Rev Oncol Hematol,2016

5. Medulloblastoma in the age of molecular subgroups: a review;Juraschka;J Neurosurg Pediatr,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of early beta-blocker initiation in acute heart failure and cardiogenic shock: systematic review and meta-analysis;The Egyptian Heart Journal;2024-09-13

2. The multifaceted role of beta‐blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders;The FASEB Journal;2024-07-08

3. Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma;Anti-Cancer Drugs;2024-04-11

4. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules;International Journal of Molecular Sciences;2024-03-31

5. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation;Clinical & Experimental Metastasis;2024-01-05